1. Formuláře: "Přidejte pomocí formuláře do listu ""data"" pacienta s následujícími hodnotami:" ID: 4 pohlaví: muž věk: 46 výška: 169 váha: 76 datum diagnózy: 8. říjen 2011 2. Automatické seznamy: "Doplňtě stadium onemocnění u všech pacientů na listu ""data"" pomocí výběru ze seznamu hodnot ""Stadium onemocnění"", který je uložen na listu ""seznamy""." 3. Automatická kontrola dat: "Povolte v listu ""data"" u proměnné ID pacienta pouze celočíselné hodnoty od 1 do 100." "Zkuste si zadat nové ID pacienta např. 2,8 nebo 101." 4. Seznamy: "Definujte nový seznam a vytvořte výčet složek seznamu bez toho, abyste jej museli vypisovat:" jedna dvě tři čtyři pět šest sedm 5. Vzorce - užitečné funkce: "Projděte a vyřešte první tři listy souboru ""Excel_Vzorce.xlxs""" ##### Sheet/List 2 ##### id pohlavi vek vyska vaha datum diagnózy stadium 1 Z 54 165 66.5 9/28/2010 2 M 62 178 82.1 4/13/2006 3 Z 59 171 58.8 7/3/2008 2 M 73 182 93.2 12/9/2008 ##### Sheet/List 3 ##### Stadium onemocnění 1 Pondělí jedna I 2 Úterý dvě II III IV neznámo id 1 3 ##### Sheet/List 4 ##### ID Date of birth Date of diagnosis Sex ISS classification M-protein type Light chain type Serum M-protein quantity (g/l) Polyclonal IgG quantity (g/l) Polyclonal IgA quantity (g/l) Polyclonal IgM quantity (g/l) Hemoglobin level (g/l) Thrombocyte count (10E9/l) Calcium total level (mmol/l) Albumin level (g/l) Creatinine level (umol/l) Beta2 microglobulin (mg/l) LDH (ukat/l) CRP (mg/l) Osteolytic lesions X-ray Date of death 1 12/26/1959 6/29/1994 F Stage 1 IgG kappa 26.0 0.48 1.70 77.0 197 2.17 36.0 76 2.50 8.14 0.0 negative 2 8/9/1945 3/3/1997 M Stage 1 Nonsecretory lambda 0.0 12.48 2.82 0.65 146.0 50.0 2.00 5.60 6.4 negative 3 7/19/1935 10/2/1997 M Stage 2 IgG lambda 48.4 87.0 210 2.50 44.0 78 3.60 6.20 0.0 negative 8/7/2012 4 7/30/1953 4/30/1998 M Stage 2 IgD lambda 16.8 8.70 1.45 0.35 106.0 270 3.08 46.0 4.90 6.84 more than 2 5 11/25/1948 11/26/1998 M Stage 1 IgG lambda 38.4 49.32 0.00 0.09 125.0 301 2.26 39.0 79 2.58 6.09 1 osteolytic lesion 40 2/2/1953 7/11/2006 M Stage 3 IgA lambda 39.8 3.20 32.93 0.17 96.0 121 2.61 36.0 107 6.03 2.62 2.0 can not evaluate 5/26/2011 6 6/6/1974 4/4/2000 M Stage 1 IgG kappa 11.3 14.43 0.80 1.08 133.0 311 37.0 2.34 7.76 49.3 1 osteolytic lesion 7 3/7/1944 7/11/2001 M Stage 1 IgG kappa 28.5 32.26 0.93 0.21 117.0 234 2.58 43.0 101 1.70 6.84 0.0 negative 3/29/2013 8 5/8/1947 3/11/2002 M Stage 2 IgG kappa 41.1 130.0 127 2.23 34.0 96 2.37 5.18 21.0 negative 3/1/2011 9 11/28/1949 4/23/2002 F Stage 2 IgG kappa 84.3 86.4 211 2.49 22.4 87 4.88 7.45 0.0 1 osteolytic lesion 6/6/2006 10 3/18/1936 7/8/2002 M Stage 2 IgG kappa 12.5 5.89 0.79 0.68 122.0 362 2.00 16.9 71 2.43 6.19 13.7 1 osteolytic lesion 11 4/13/1944 11/27/2002 M Stage 1 IgM kappa 7.9 123.0 320 2.35 41.1 88 1.82 4.31 0.0 2 osteolytic lesions 2/19/2009 12 2/25/1943 2/25/2003 F Stage 1 IgA lambda 25.3 6.00 28.70 0.45 129.0 218 2.36 48.5 96 2.33 2.2 can not evaluate 13 4/17/1950 6/3/2003 F Stage 1 IgG lambda 34.1 96.0 191 2.37 45.2 75 2.11 5.52 6.8 negative 14 5/18/1944 6/12/2003 F Stage 1 IgG lambda 31.8 45.30 0.26 0.28 120.0 182 2.28 38.1 86 1.51 2.0 negative 15 8/23/1964 7/1/2003 M Stage 3 LC only lambda 4.7 7.00 0.79 0.13 89.0 227 2.39 43.0 283 7.84 8.17 5.0 more than 2 3/18/2010 16 12/8/1958 8/11/2003 M Stage 1 IgG kappa 24.6 26.51 2.98 1.29 142.0 289 2.33 46.3 106 1.28 7.91 3.4 negative 17 5/13/1949 12/10/2003 M Stage 1 IgG kappa 0.0 154.0 242 2.49 47.8 90 1.43 7.43 negative 18 8/26/1955 1/14/2004 M Stage 3 IgD kappa 3.7 6.80 0.74 0.13 94.0 254 3.11 32.0 264 5.69 35.1 more than 2 7/3/2004 19 11/7/1939 3/29/2004 M Stage 1 IgG kappa 31.5 34.41 0.68 0.68 107.0 167 2.30 38.5 91 1.18 5.55 0.0 2 osteolytic lesions 10/28/2012 20 3/20/1942 4/15/2004 M Stage 1 IgM kappa 20.7 4.50 0.10 32.10 111.0 267 2.68 43.1 77 1.40 2.6 more than 2 4/10/2011 21 6/24/1949 5/26/2004 F Stage 1 IgG kappa 23.0 30.67 0.25 0.22 100.0 227 2.08 39.7 66 1.23 7.37 0.5 negative 2/6/2013 22 4/14/1940 8/26/2004 F Stage 1 IgG kappa 25.7 105.0 220 2.58 42.4 96 3.72 0.0 negative 23 8/31/1950 8/31/2004 M Stage 3 IgD kappa 31.1 81.9 328 2.14 34.1 444 7.44 11.03 64.4 more than 2 1/28/2010 24 5/13/1944 9/27/2004 M Stage 3 Biclonal lambda 15.2 1.90 0.07 0.08 114.0 141 2.85 32.5 287 5.60 4.4 1 osteolytic lesion 25 4/13/1941 10/19/2004 F Stage 1 IgM lambda 24.2 134.0 374 2.51 42.4 68 1.54 5.76 0.4 negative 11/1/2009 26 5/18/1946 12/15/2004 M Stage 1 IgG lambda 31.9 34.35 0.82 0.63 129.0 296 2.36 42.6 118 2.72 5.81 15.5 1 osteolytic lesion 27 6/21/1940 1/12/2005 M Stage 3 IgD lambda 3.4 7.35 1.13 0.00 129.0 232 2.77 43.1 196 6.37 4.5 can not evaluate 28 1/19/1970 2/23/2005 F Stage 3 LC only lambda 0.0 68.0 113 3.50 41.0 237 12.20 5.30 43.8 more than 2 2/29/2012 29 2/25/1950 3/3/2005 M Stage 2 LC only lambda 0.0 133.0 223 2.55 41.0 94 3.0 more than 2 30 7/28/1939 3/11/2005 F Stage 1 Biclonal lambda 34.4 8.27 33.99 0.16 125.0 275 2.64 43.3 71 2.02 3.56 0.3 more than 2 6/20/2007 31 8/12/1942 3/24/2005 M Stage 2 IgG lambda 0.0 58.83 0.09 0.58 84.0 86 2.07 48.0 129 5.03 13.23 4.4 negative 7/5/2010 32 2/14/1961 4/11/2005 F Stage 1 LC only kappa 0.0 6.57 0.26 0.42 97.0 227 2.63 44.0 60 2.51 7.51 5.0 more than 2 4/30/2013 33 6/11/1958 5/3/2005 M Stage 1 LC only kappa 0.0 7.48 0.14 0.00 103.0 175 2.19 38.0 84 2.39 4.9 more than 2 9/28/2012 34 7/31/1939 8/25/2005 F Stage 1 LC only kappa 0.0 5.61 0.37 0.33 111.0 495 2.63 46.4 68 2.19 6.60 5.0 more than 2 4/21/2009 35 1/6/1961 11/9/2005 F Stage 3 IgG kappa 28.6 29.10 0.33 0.33 131.0 302 2.58 47.7 67 15.12 2.57 negative 36 5/19/1952 3/23/2006 M Stage 1 IgG lambda 4.8 152.0 247 2.35 45.7 72 1.70 8.84 1.0 2 osteolytic lesions 1/2/2009 37 6/8/1939 4/12/2006 F Stage 1 IgA lambda 10.6 8.00 15.20 0.44 144.0 266 2.33 43.6 73 1.62 2.70 2.2 can not evaluate 38 4/19/1946 5/18/2006 F Stage 1 IgG lambda 11.7 13.80 1.98 1.25 125.0 300 2.50 47.5 73 2.19 3.50 5.5 more than 2 39 8/29/1931 5/31/2006 M Stage 3 IgG lambda 94.4 78.0 119 2.24 46.4 124 5.71 1.0 negative 12/2/2010 40 2/2/1953 7/11/2006 M Stage 3 IgA lambda 39.8 3.20 32.93 0.17 96.0 121 2.61 36.0 107 6.03 2.62 2.0 can not evaluate 5/26/2011 41 8/7/1950 9/26/2006 M Stage 1 IgG lambda 15.2 24.50 2.19 0.69 98.0 15 2.30 37.0 67 2.06 3.70 2.0 negative 42 1/24/1947 12/14/2006 F Stage 2 IgG lambda 31.1 117.0 144 2.24 37.3 78 2.50 2.83 1.0 negative 43 2/28/1953 12/27/2006 M Stage 1 LC only lambda 0.0 19.70 4.96 0.53 136.0 349 2.41 48.0 88 1.75 2.85 4.9 more than 2 7/28/2011 44 6/13/1933 1/4/2007 MM Stage 2 Biclonal lambda 24.8 22.56 6.58 0.66 111.0 312 2.26 29.7 203 4.62 3.69 40.2 more than 2 2/11/2012 45 5/4/1943 2/22/2007 F Stage 2 IgG lambda 74.5 48.80 0.15 0.18 83.0 150 2.27 37.0 93 5.50 2.83 12.7 negative 11/22/2009 46 1/6/1948 3/2/2007 F Stage 1 IgG kappa 29.1 38.50 0.53 0.51 131.0 207 2.33 46.0 65 1.06 3.40 2.0 negative 47 10/27/1948 3/28/2007 F Stage 2 LC only kappa 0.0 6.50 0.68 0.53 115.0 371 2.89 50.0 127 3.54 3.72 4.1 more than 2 48 12/16/1945 4/10/2007 M Stage 2 IgG lambda 16.9 19.70 0.31 0.48 114.0 212 2.17 26.8 80 2.11 2.50 45.5 negative 49 1/10/1923 5/18/2007 M Stage 2 IgG lambda 15.6 18.30 0.68 0.71 105.0 241 2.32 37.5 101 3.35 3.12 4.7 negative 1/2/2008 50 8/4/1932 5/24/2007 M Stage 1 Nonsecretory lambda 0.0 137.0 178 2.25 39.7 128 3.03 3.58 11.3 negative 9/6/2008 51 1/6/1934 5/24/2007 M Stage 1 LC only lambda 0.0 6.70 1.11 0.48 116.0 233 2.55 46.0 108 3.18 4.18 4.0 more than 2 1/15/2010 52 1/15/1960 6/25/2007 F Stage 3 IgD lambda 11.9 5.52 0.53 0.30 90.1 224 3.62 39.0 532 15.70 4.64 62.0 more than 2 4/28/2010 53 7/16/1946 6/26/2007 F Stage 1 IgG lambda 18.7 23.50 0.17 0.12 144.0 203 2.19 40.3 79 3.02 2.90 2.0 negative 54 8/14/1941 6/27/2007 M Stage 2 IgG lambda 69.6 81.0 162 1.84 25.6 113 13.00 2.69 6.0 negative 55 9/8/1945 7/20/2007 M Stage 2 Biclonal lambda 26.3 31.88 0.50 0.27 107.0 252 2.09 26.1 119 4.47 3.84 56.4 more than 2 1/15/2010 56 2/11/1941 10/3/2007 M Stage 2 IgD lambda 31.7 3.40 0.20 0.12 66.0 121 2.35 41.0 94 4.34 3.18 1.0 negative 5/26/2009 57 1/11/1976 10/26/2007 M Stage 1 Nonsecretory lambda 0.0 6.92 2.33 1.30 125.0 321 2.25 38.3 67 1.04 3.88 39.2 negative 6/12/2014 58 2/10/1937 11/6/2007 F Stage 3 IgD lambda 8.0 3.90 0.18 0.42 81.0 206 3.58 39.0 223 8.90 7.60 27.0 more than 2 8/2/2008 59 5/9/1949 11/8/2007 F Stage 1 IgG lambda 45.5 135.0 228 2.24 38.7 85 2.00 4.56 negative 60 3/26/1948 2/14/2008 F Stage 1 IgG lambda 7.8 14.30 0.38 0.08 108.0 256 2.56 50.0 62 2.53 3.51 3.7 negative 3/25/2012 61 3/15/1941 2/19/2008 F Stage 2 IgG kappa 53.7 102.0 278 3.90 30.3 61 2.39 79.0 negative 11/7/2010 62 7/6/1953 3/4/2008 F Stage 3 IgD kappa 7.8 3.08 0.15 0.10 65.8 115 3.32 33.8 533 9.59 4.07 31.3 more than 2 12/1/2008 63 4/15/1925 3/11/2008 M Stage 1 IgG kappa 29.0 43.18 0.93 1.27 111.0 198 2.22 38.0 92 2.89 3.34 2.9 negative 64 11/20/1932 3/20/2008 F Stage 1 IgG lambda 21.7 145.0 276 2.16 40.0 90 3.40 38.0 negative 9/16/2009 65 4/20/1932 4/9/2008 M Stage 2 IgG lambda 36.4 43.46 0.18 0.19 99.4 187 2.64 40.0 94 4.93 2.71 27.4 1 osteolytic lesion 10/10/2008 66 6/11/1921 4/11/2008 F Stage 2 IgG lambda 20.3 26.13 0.68 1.23 108.0 202 2.41 38.9 111 4.70 3.44 3.4 2 osteolytic lesions 12/28/2010 67 6/20/1933 4/24/2008 F Stage 1 IgG lambda 28.8 124.0 240 2.36 46.9 53 2.00 negative 2/8/2012 68 12/18/1935 5/6/2008 M Stage 1 Nonsecretoory lambda 1.4 6.50 0.55 0.32 97.0 287 2.31 70.1 105 2.07 4.70 10.9 more than 2 5/1/2010 69 1/21/1945 5/21/2008 M Stage 1 Nonsecretory lambda 0.0 7.59 1.43 1.30 136.0 264 2.46 46.0 92 1.34 4.55 negative 70 4/25/1948 6/17/2008 F Stage 1 IgA lambda 15.8 2.79 18.00 0.19 82.0 184 2.91 48.8 525 1.99 2.56 37.0 9/6/2008 71 4/17/1946 6/25/2008 M Stage 2 IgG lambda 4.6 109.0 536 2.00 32.0 70 3.74 49.0 2 osteolytic lesions 3/22/2014 72 8/25/1922 7/17/2008 M Stage 3 LC only lambda 2.1 8.93 1.23 0.50 99.9 60 2.51 51.3 430 10.10 5.18 1.0 negative 11/25/2008 73 3/12/1971 7/29/2008 F Stage 2 LC only lambda 0.0 15.73 1.17 0.44 92.0 748 2.53 39.0 61 4.20 3.30 86.6 more than 2 74 12/25/1939 8/1/2008 M Stage 1 IgD kappa 0.0 7.58 0.47 0.20 95.0 192 2.35 45.0 116 1.84 6.23 1.0 negative 9/22/2010 75 4/14/1937 8/11/2008 F Stage 3 Nonsecretory kappa 0.0 2.65 0.24 0.19 68.0 73 2.49 42.0 107 6.32 3.51 7.0 negative 7/6/2009 76 3/6/1951 8/28/2008 F Stage 1 IgG kappa 32.6 33.64 0.35 0.47 138.0 217 2.54 38.9 52 2.14 3.31 1.1 2 osteolytic lesions 8/29/2011 77 11/23/1935 9/15/2008 M Stage 1 IgM kappa 1.3 10.50 1.59 1.28 130.0 302 2.36 44.4 68 2.54 9.20 13.2 1 osteolytic lesion 78 11/23/1952 10/8/2008 M Stage 1 IgG kappa 1.8 9.92 1.96 0.47 143.0 175 2.63 43.6 86 2.29 3.42 negative 79 12/26/1935 10/20/2008 F Stage 3 IgG lambda 60.0 76.80 78.0 240 2.69 28.8 226 20.20 3.46 9.0 negative 6/23/2011 80 3/9/1929 11/25/2008 F Stage 3 IgG lambda 64.0 73.00 0.16 0.17 98.6 194 3.12 31.0 201 6.44 2.96 7.1 2 osteolytic lesions 12/3/2013 81 3/3/1945 12/12/2008 M Stage 3 LC only lambda 0.0 6.25 0.41 0.19 93.0 98 2.33 33.0 660 14.41 3.02 5.5 more than 2 82 2/21/1958 2/12/2009 F Stage 1 IgG lambda 26.8 47.60 0.10 0.23 130.0 165 2.18 39.1 60 3.30 2.59 24.0 negative 83 10/15/1928 2/27/2009 F Stage 3 Biclonal lambda 5.0 10.01 0.84 4.53 98.0 187 2.22 40.0 62 6.20 4.17 14.4 more than 2 1/16/2011 84 2/1/1959 3/12/2009 M Stage 1 IgG lambda 35.3 37.52 0.49 0.11 139.0 191 2.32 85 1.80 2.21 3.0 negative 85 1/4/1959 3/13/2009 M Stage 1 IgG lambda 5.6 152.0 292 2.34 45.5 91 1.35 2.71 0.0 1 osteolytic lesion 86 2/3/1941 3/25/2009 M Stage 3 IgG lambda 12.2 20.44 0.80 0.64 95.0 240 2.05 41.1 217 6.24 2.75 12.7 negative 87 3/7/1946 4/9/2009 M Stage 3 IgA lambda 8.2 14.30 8.22 1.74 124.0 400 1.88 39.9 111 6.31 2.10 7.8 can not evaluate 88 9/12/1946 5/18/2009 F Stage 3 IgG lambda 17.4 27.18 0.33 0.54 139.0 337 2.29 30.5 371 6.94 3.92 2.9 negative 12/12/2011 89 3/26/1961 5/19/2009 M Stage 1 IgG lambda 2.2 6.70 0.92 0.94 165.0 478 2.14 48.1 79 1.25 2.88 1.8 negative 90 1/9/1932 6/3/2009 F Stage 3 IgG lambda 60.8 90.0 210 2.17 24.5 151 8.30 14.0 negative 91 5/26/1952 6/4/2009 M Stage 2 IgD kappa 35.5 113.0 370 2.39 44.7 86 3.80 3.17 9.0 negative 92 3/6/1943 6/24/2009 F Stage 2 Biclonal kappa 19.1 24.90 0.22 0.22 139.0 421 2.46 30.2 44 2.57 2.30 5.3 more than 2 11/16/2009 93 1/11/1944 7/3/2009 M Stage 1 IgG kappa 11.7 32.10 3.36 1.17 138.0 289 2.34 45.8 88 1.70 2.10 6.1 negative 94 3/27/1950 7/25/2009 M Stage 2 IgG kappa 62.0 51.20 0.15 0.09 115.0 201 1.92 25.7 89 2.19 2.73 1.0 negative 2/19/2010 95 6/19/1968 8/6/2009 M Stage 1 Nonsecretory lambda 0.0 11.63 0.78 0.54 162.0 237 2.63 54.5 102 2.02 4.74 1.1 negative 96 5/24/1949 8/6/2009 F Stage 1 IgG lambda 65.2 93.0 209 2.12 35.9 53 3.18 2.80 3.0 2 osteolytic lesions 97 7/20/1929 8/27/2009 M Stage 1 Biclonal lambda 2.8 13.80 3.48 3.40 140.0 472 2.29 45.6 98 2.37 2.70 negative 1/29/2012 98 10/5/1948 9/2/2009 M Stage 3 Biclonal lambda 60.6 76.60 1.06 0.79 98.0 178 1.80 24.7 136 8.80 1.58 23.0 more than 2 99 9/4/1932 9/2/2009 M Stage 3 IgG lambda 88.0 102.42 0.18 0.04 91.0 95 1.86 22.3 183 8.40 2.01 6.4 negative 8/27/2010 100 12/13/1950 9/8/2009 M Stage 3 LC only lambda 17.4 3.05 0.21 0.07 78.5 118 2.30 38.5 753 30.90 3.05 4.8 negative 101 5/29/1942 9/8/2009 F Stage 2 IgG lambda 63.6 58.30 0.15 0.13 134.0 114 3.46 28.5 396 1.90 6.40 2.0 negative 1/11/2010 102 4/28/1932 9/10/2009 M Stage 2 Biclonal lambda 13.3 24.70 4.57 1.79 117.0 189 2.03 33.9 98 4.46 4.40 71.8 more than 2 11/15/2009 103 4/20/1929 9/15/2009 F Stage 3 IgG lambda 48.0 89.0 177 3.26 29.6 289 negative 10/9/2009 104 3/14/1928 10/19/2009 M Stage 2 IgG lambda 14.1 18.23 0.53 0.11 87.0 265 2.18 43.6 134 3.95 2.37 negative 105 1/25/1956 10/23/2009 F Stage 2 IgG lambda 63.6 74.48 1.92 3.15 90.7 201 2.69 38.1 118 4.19 8.09 5.3 negative 7/7/2010 106 4/8/1925 11/9/2009 F Stage 3 IgG lambda 17.0 23.45 0.10 0.10 89.0 88 42.0 130 9.32 4.12 5.0 negative 107 4/1/1941 11/15/2009 F Stage 3 IgD kappa 17.2 3.60 0.41 0.19 74.0 250 2.10 29.1 243 11.05 4.30 2.8 can not evaluate 108 1/1/1938 12/2/2009 F Stage 1 IgG kappa 38.1 54.40 0.15 0.25 113.0 278 2.27 36.5 88 3.40 1.5 negative 8/12/2011 109 1/22/1936 12/15/2009 M Stage 3 LC only kappa 34.0 30.90 0.18 0.29 100.0 201 2.13 41.9 88 6.27 10.10 1.0 more than 2 9/2/2012 110 3/8/1942 1/18/2010 F Stage 1 IgA kappa 18.4 7.15 0.69 116.0 208 2.60 40.0 88 2.50 2.24 0.0 more than 2 111 5/22/1937 3/18/2010 F Stage 3 IgA kappa 59.5 100.0 147 2.29 24.1 95 7.40 3.03 50.8 112 4/26/1931 4/22/2010 M Stage 2 Nonsecretory lambda 0.0 106.0 309 1.22 33.2 54 1.66 3.05 19.3 more than 2 12/14/2011 113 10/1/1932 4/28/2010 M Stage 1 Nonsecretory lambda 0.0 120.0 235 2.01 39.0 61 2.20 5.30 2.8 negative 6/27/2012 114 9/28/1945 4/28/2010 M Stage 1 IgG lambda 34.1 34.66 1.59 0.64 110.0 586 2.45 39.0 88 3.00 2.46 63.7 negative 115 1/31/1948 5/21/2010 M Stage 3 LC only lambda 7.5 3.18 0.22 0.19 103.0 294 2.38 36.6 694 50.00 5.11 59.0 can not evaluate 7/24/2010 116 5/12/1928 6/4/2010 M Stage 3 IgG lambda 31.1 62.40 0.11 0.05 89.8 197 1.95 30.7 195 6.03 7.15 9.0 negative 8/8/2010 117 3/24/1932 6/15/2010 F Stage 3 LC only lambda 6.6 7.69 0.54 0.14 82.0 217 2.41 32.7 569 33.99 can not evaluate 7/1/2010 118 9/30/1944 6/21/2010 M Stage 3 IgG kappa 51.2 91.09 1.07 68.0 65 1.91 32.2 334 15.00 4.86 26.1 negative 4/23/2013 119 3/16/1942 7/7/2010 M Stage 2 IgG kappa 15.0 17.20 0.50 0.39 127.0 182 2.24 32.6 122 140.9 1 osteolytic lesion 11/25/2012 120 8/2/1929 7/19/2010 F Stage 2 Biclonal kappa 39.6 3.00 53.00 0.10 121.0 213 2.14 30.8 76 4.43 1.90 20.1 more than 2 10/14/2010 121 11/20/1951 8/5/2010 M Stage 3 IgG kappa 36.0 122.0 288 2.19 36.0 121 5.90 negative 122 10/31/1951 8/26/2010 M Stage 3 LC only kappa 1.0 3.47 0.13 0.00 94.0 147 2.38 47.0 127 8.97 5.53 3.7 negative 123 1/26/1928 8/31/2010 M Stage 1 LC only kappa 0.0 7.05 0.33 0.24 134.0 116 2.56 45.8 97 2.98 3.73 3.0 more than 2 124 5/6/1941 10/20/2010 F Stage 2 IgG lambda 36.7 56.34 0.13 0.06 85.0 129 -3.21 27.6 173 3.61 1.36 1.9 2 osteolytic lesions 4/10/2013 125 7/10/1957 10/21/2010 M Stage 3 LC only lambda 11.9 72.0 56 2.52 38.6 810 13.50 1.88 276.3 negative 1/20/2011 126 10/18/1935 10/21/2010 F Stage 1 IgG lambda 23.0 26.10 0.45 0.30 113.0 148 2.37 39.0 59 2.33 3.51 0.0 negative 127 8/22/1953 11/11/2010 F Stage 1 IgG lambda 30.5 44.40 0.94 1.05 115.0 202 2.34 42.0 93 2.64 2.60 1.0 negative 128 1/30/1962 11/26/2010 M Stage 1 LC only lambda 0.0 2.53 0.22 0.51 134.0 159 2.35 38.6 111 2.28 5.08 3.1 negative 129 7/25/1929 11/29/2010 F Stage 3 IgG lambda 15.1 22.57 2.50 0.39 101.0 284 2.43 39.7 179 6.67 3.01 1.5 negative 6/22/2012 130 2/18/1957 11/30/2010 M Stage 3 LC only lambda 0.0 95.0 62 2.43 40.0 66 5.51 2.20 6.6 more than 2 131 6/20/1951 12/8/2010 M Stage 1 IgG lambda 25.0 37.03 0.76 0.27 141.0 337 2.15 42.9 76 2.34 2.97 1.0 1 osteolytic lesion 132 6/20/1940 12/10/2010 M Stage 2 IgM lambda 6.9 134.0 164 2.29 37.0 118 4.71 1.0 more than 2 2/21/2011 133 11/27/1945 12/22/2010 M Stage 3 IgD lambda 3.0 5.25 0.90 0.19 112.0 293 4.23 43.7 285 12.70 32.09 27.0 more than 2 1/6/2011 134 2/2/1947 1/13/2011 M Stage 2 IgD lambda 14.2 6.27 0.55 0.18 112.0 180 2.42 42.8 111 4.63 3.87 4.5 more than 2 10/19/2011 135 7/20/1934 2/8/2011 F Stage 3 IgG lambda 42.4 45.63 0.10 0.30 81.0 213 1.96 29.3 240 30.20 4.36 10.4 negative 136 1/14/1939 2/14/2011 M Stage 3 Nonsecretory lambda 0.0 2.90 0.13 0.12 108.0 105 2.53 43.0 147 9.55 3.80 1.0 can not evaluate 5/29/2012 137 8/1/1937 2/14/2011 M Stage 3 IgG lambda 12.8 12.23 0.13 0.07 75.0 118 1.98 34.2 783 21.10 2.46 1.0 negative 11/23/2013 138 2/14/1934 2/15/2011 F Stage 2 Biclonal kappa 19.8 105.0 181 2.04 21.3 72 3.01 72.2 negative 139 3/23/1957 2/15/2011 F Stage 3 LC only kappa 4.4 7.90 0.37 0.20 102.0 262 2.06 34.2 125 20.10 2.60 1.0 can not evaluate 140 6/12/1938 2/24/2011 M Stage 1 IgG kappa 26.0 29.50 0.18 0.17 108.0 232 2.18 37.7 108 2.94 4.06 1.0 negative 3/18/2012 141 1/8/1940 3/24/2011 M Stage 2 LC only kappa 0.0 81.0 231 1.78 15.0 46 3.29 2.55 164.0 more than 2 5/29/2011 142 9/4/1938 5/4/2011 M Stage 3 IgG kappa 61.7 76.14 0.77 0.68 87.0 127 2.43 24.3 199 8.73 9.73 5.3 1 osteolytic lesion 10/28/2011 143 6/11/1953 5/5/2011 M Stage 2 IgG lambda 60.6 99.0 361 2.18 33.9 72 5.41 2.28 9.7 negative 144 9/20/1935 5/16/2011 M Stage 3 IgG lambda 65.6 74.83 0.34 0.34 107.0 217 2.18 32.1 77 6.39 3.39 1.0 2 osteolytic lesions 3/1/2012 145 8/3/1935 5/17/2011 M Stage 3 IgG lambda 75.0 80.10 0.19 0.18 65.0 375 2.03 22.0 209 14.23 2.25 23.4 more than 2 5/28/2013 146 5/27/1944 5/17/2011 M Stage 1 IgG lambda 5.7 7.55 1.95 0.59 121.0 250 2.18 35.0 72 1.57 5.98 3.9 1 osteolytic lesion 147 2/14/1935 5/20/2011 M Stage 3 Biclonal lambda 15.7 6.11 17.16 0.58 128.0 172 2.33 37.8 242 8.03 4.03 2.2 can not evaluate 2/13/2012 148 9/22/1947 6/13/2011 M Stage 3 IgG lambda 31.8 33.58 0.12 0.11 123.0 119 2.68 39.2 108 10.50 5.20 2.3 2 osteolytic lesions 10/30/2011 149 2/22/1936 6/14/2011 M Stage 3 IgA lambda 34.1 105.0 172 3.16 27.6 119 27.2 can not evaluate 150 2/14/1930 6/30/2011 M Stage 3 IgG lambda 45.9 123.0 144 2.29 33.6 88 4.80 2.80 1.0 negative 9/4/2011 151 2/23/1933 7/13/2011 M Stage 3 IgG kappa 48.3 123.0 204 2.54 34.4 209 23.00 4.75 10.9 negative 10/26/2011 152 7/16/1960 7/18/2011 M Stage 3 LC only kappa 1.4 2.28 0.14 0.09 166.0 344 3.29 46.1 75 5.61 3.11 1.0 negative 153 12/24/1946 7/28/2011 F Stage 3 LC only kappa 2.4 3.15 0.17 0.05 94.0 177 2.91 41.9 883 48.40 3.00 1.4 negative 7/9/2012 154 9/3/1951 8/8/2011 F Stage 2 IgG kappa 3.6 7.77 0.88 0.19 122.0 199 2.24 42.0 92 3.99 3.25 3.9 1 osteolytic lesion 155 8/4/1948 8/12/2011 M Stage 2 IgG kappa 45.3 44.38 0.42 0.34 167.0 122 2.14 30.4 62 2.09 3.59 1.0 negative 7/26/2013 156 4/14/1935 9/20/2011 M Stage 2 IgG kappa 48.0 64.60 0.15 0.24 94.0 139 2.10 27.0 114 3.40 2.64 12.2 negative 157 6/20/1944 9/26/2011 F Stage 1 IgG lambda 48.5 48.40 0.29 0.08 102.0 279 2.49 36.9 81 2.39 2.03 1.0 1 osteolytic lesion 158 9/20/1946 9/29/2011 M Stage 1 IgM lambda 1.6 11.00 2.08 0.96 157.0 267 2.55 46.3 93 2.94 4.80 2.1 more than 2 159 7/2/1935 10/6/2011 M Stage 3 IgG lambda 27.6 28.34 1.48 0.58 129.0 277 2.10 33.9 302 10.10 5.16 8.0 2 osteolytic lesions 4/1/2014 160 6/29/1931 12/13/2011 F Stage 3 Biclonal lambda 6.8 5.92 9.26 0.07 112.0 216 2.62 43.4 174 18.60 3.44 1.4 more than 2 161 5/3/1935 12/13/2011 M Stage 2 IgG lambda 35.2 126.0 205 2.17 30.5 119 5.28 2.20 4.6 negative 2/7/2014 162 6/27/1949 12/15/2011 M Stage 1 Nonsecretory lambda 0.0 149.0 291 2.35 53.1 82 1.42 2.80 1.0 negative 163 10/31/1950 12/15/2011 F Stage 1 IgG lambda 24.0 26.66 0.55 0.38 130.0 226 2.54 47.0 59 2.50 2.92 14.8 negative 164 11/9/1974 12/27/2011 M Stage 2 LC only lambda 0.0 170.0 255 2.56 44.3 124 3.81 3.27 2.9 more than 2 165 3/3/1942 12/28/2011 M Stage 2 Biclonal lambda 24.7 33.12 4.34 1.02 137.0 273 2.56 33.0 87 3.10 3.44 5.0 more than 2 2/21/2012 166 11/4/1943 1/24/2012 M Stage 2 IgG kappa 0.0 129.0 205 2.15 33.8 85 2.50 4.94 3.1 negative 167 5/14/1940 1/27/2012 M Stage 3 Biclonal kappa 63.0 70.25 0.61 0.24 72.0 168 2.72 22.4 244 29.90 2.52 14.4 more than 2 8/4/2013 168 9/6/1950 2/1/2012 M Stage 2 IgG kappa 27.5 38.99 0.45 0.24 127.0 337 2.30 34.6 84 3.40 3.80 16.0 1 osteolytic lesion 169 2/3/1950 2/28/2012 F Stage 3 IgG kappa 42.0 44.80 0.28 1.37 95.0 231 2.28 30.0 84 12.91 2.97 18.8 negative 170 9/10/1950 3/13/2012 F Stage 1 IgG kappa 27.0 30.13 0.65 0.66 116.0 179 2.09 40.0 51 2.14 2.54 0.0 negative 171 6/26/1934 3/27/2012 F Stage 3 IgA kappa 18.8 5.95 34.54 0.21 81.1 185 1.82 22.8 420 13.90 2.23 34.1 4/4/2012 172 11/11/1952 4/5/2012 F Stage 1 LC only kappa 5.5 6.00 0.30 0.30 137.0 205 2.50 49.4 64 3.33 7.00 4.4 more than 2 173 6/5/1937 4/19/2012 F Stage 1 IgG lambda 40.0 41.88 0.23 0.27 89.0 137 2.39 40.0 75 3.48 3.2 1 osteolytic lesion 174 3/25/1960 4/23/2012 M Stage 3 LC only lambda 1.6 8.00 1.05 0.23 93.0 187 2.71 29.5 672 16.87 2.90 63.4 more than 2 175 11/1/1955 4/24/2012 M Stage 1 IgG lambda 19.0 134.0 136 2.33 39.4 93 2.20 2.23 0.4 negative 176 8/7/1933 4/25/2012 F Stage 2 IgM lambda 41.1 3.54 1.61 110.0 205 2.67 34.9 60 1.60 3.22 5.5 negative 9/1/2012 177 3/5/1933 5/9/2012 F Stage 2 IgG lambda 23.3 29.65 0.59 0.31 110.0 115 2.24 40.5 93 3.78 2.70 5.0 2 osteolytic lesions 5/22/2014 178 5/20/1940 5/29/2012 M Stage 2 IgA lambda 17.5 115.0 223 2.23 37.6 117 3.60 3.90 1.0 can not evaluate 179 6/5/1947 6/11/2012 M Stage 2 LC only lambda 1.4 8.60 1.16 0.16 119.0 267 2.18 46.5 252 4.76 2.50 3.2 more than 2 180 6/22/1948 7/3/2012 M Stage 2 IgA lambda 17.4 117.0 135 3.79 29.9 440 0.28 3.87 127.9 9/7/2013 181 12/13/1934 7/12/2012 M Stage 3 LC only lambda 0.0 5.16 0.66 0.16 77.0 91 2.40 38.1 230 7.77 3.28 2.3 negative 6/4/2013 182 5/23/1951 7/17/2012 M Stage 3 IgG lambda 78.0 80.50 0.16 0.14 77.0 86 1.79 25.0 1383 34.60 2.48 18.3 negative 11/13/2014 183 6/19/1943 7/23/2012 F Stage 1 LC only lambda 0.0 4.45 0.55 0.17 117.0 186 2.27 46.5 59 2.21 3.80 1.0 more than 2 10/26/2013 184 5/9/1956 8/21/2012 M Stage 2 IgG lambda 20.9 25.68 2.14 1.08 106.0 234 2.20 17.7 82 4.26 2.38 15.5 negative 5/24/2013 185 9/1/1932 8/21/2012 M Stage 3 IgG kappa 53.1 71.90 0.31 0.08 90.7 63 2.09 22.5 369 44.90 7.77 7.9 negative 8/26/2012 186 6/1/1941 8/29/2012 F Stage 1 IgG kappa 23.0 101.0 271 2.04 35.9 70 1.50 2.96 3.2 negative 187 6/9/1947 9/13/2012 M Stage 2 IgG kappa 28.1 91.0 140 2.17 124 4.40 11.0 negative 1/18/2013 188 2/20/1944 10/4/2012 M Stage 1 IgG kappa 3.0 5.73 1.43 0.17 164.0 237 2.46 47.8 115 1.42 2.36 2.8 negative 189 4/4/1941 10/18/2012 F Stage 2 LC only kappa 0.0 120.0 369 1.96 45.1 76 3.58 3.80 70.2 more than 2 11/30/2012 190 11/11/1944 10/24/2012 F Stage 2 IgG kappa 49.2 100.0 254 2.25 29.0 74 3.79 1.80 1.7 negative 191 9/1/1940 10/30/2012 F Stage 3 LC only kappa 0.0 3.79 0.17 0.05 96.0 334 2.22 46.0 234 10.01 3.80 38.2 more than 2 192 7/30/1936 11/16/2012 F Stage 3 LC only lambda 5.0 5.40 0.26 0.17 105.0 269 3.33 34.8 245 13.10 4.06 9.1 11/28/2012 193 8/21/1943 12/10/1900 F Stage 3 IgA lambda 10.0 6.60 13.50 0.31 86.0 296 2.63 37.0 392 27.60 3.07 33.9 negative 194 6/28/1959 3/19/2013 M Stage 1 IgG lambda 20.4 31.50 2.27 1.71 154.0 157 2.13 37.3 79 1.58 2.80 4.5 negative 195 4/15/1939 5/23/2013 F Stage 3 IgG lamdba 43.0 49.30 0.86 0.77 100.0 183 2.08 36.0 91 8.20 3.00 37.6 negative 12/10/2013 196 4/18/1954 8/6/2013 M Stage 3 IgG kappa 27.9 32.50 0.52 0.26 85.6 172 2.16 31.4 1204 34.40 2.47 64.0 negative 12/14/2013 197 7/29/1944 10/16/2013 F Stage 3 IgG kappa 0.4 37.30 0.63 0.39 93.0 228 2.09 34.0 74 5.55 can not evaluate 4/7/2014 198 6/4/1945 10/29/2013 M Stage 3 Biclonal kappa 9.1 7.90 10.80 0.28 129.0 219 2.27 45.7 126 5.77 2.40 6.7 negative 12/7/2014 199 2/7/1959 1/7/2014 F Stage 3 LC only lambda 3.5 5.93 0.26 0.04 88.0 224 2.24 43.9 237 15.93 4.69 14.0 negative 8/7/2014 200 8/21/1943 9/13/2012 F Stage 1 LC only lambda 0.4 7.90 13.50 1.71 85.6 234 2.46 34.8 79 27.60 4.06 9.1 more than 2 8/7/2014